You are in: eMedicine Specialties > Ophthalmology > CORNEA Dystrophy, LatticeArticle Last Updated: Mar 15, 2006AUTHOR AND EDITOR INFORMATIONAuthor: William Trattler, MD, Miami Center for Excellence in Eye Care; Consulting Staff, Department of Ophthalmology, Miami Baptist Hospital William Trattler is a member of the following medical societies: American Academy of Ophthalmology Coauthor(s): William Lloyd Clark, MD, Consulting Staff, Palmetto Retina; Natalie Afshari, MD, Assistant Professor, Cornea and Refractive Surgery, Department of Ophthalmology, Duke University Eye Center, Duke University Medical Center Editors: Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences Author and Editor Disclosure Synonyms and related keywords: lattice dystrophy, corneal dystrophy, stromal dystrophy, stromal dystrophies, corneal erosion, corneal transplant, phototherapeutic keratectomy, PTK INTRODUCTIONBackgroundLattice dystrophy usually is an autosomal dominant condition, and it is the most common of stromal dystrophies. Like granular and Avellino dystrophy, the genetic defect of lattice dystrophy has been mapped to the BIG H3 gene on chromosome 5q. Onset of the corneal changes usually occurs in the first decade of life, although patients may remain asymptomatic for years. Examination of the cornea in the second to third decade of life will reveal branching, refractile lattice lines with intervening haze, which are observed best in retroillumination. PathophysiologyThe cornea is the clear outer coat of the front of the eye. A dystrophy of the cornea is defined as a bilateral noninflammatory clouding of the cornea. The corneal dystrophies can be placed into 3 categories based on their location within the cornea as follows: (1) the anterior corneal dystrophies affect the corneal epithelium and may involve the Bowman membrane, (2) stromal corneal dystrophies affect the central layer of the cornea (the stroma), and (3) the posterior corneal dystrophies involve the Descemet membrane and the endothelium. Most corneal dystrophies have an onset prior to age 20 years (exceptions include map-dot-fingerprint dystrophy and Fuchs corneal dystrophy). Most corneal dystrophies are dominantly inherited, exceptions are macular dystrophy, type 3 lattice dystrophy, and the autosomal-recessive form of congenital hereditary endothelial dystrophy. FrequencyUnited StatesAlthough lattice dystrophy is the most common of the stromal dystrophies, it is relatively rare. Mortality/MorbidityExcessive corneal erosions can lead to decreased visual acuity, which may require a corneal transplant or phototherapeutic keratectomy (PTK). SexNo sexual predilection exists. AgeOnset of the corneal changes usually occurs in the first decade of life, although patients may remain asymptomatic for years. Examination of the cornea in the second to third decade of life reveals branching, refractile lattice lines, which are observed best in retroillumination. Over time, the lattice lines and other opacities coalesce, forming anterior stromal haze that decreases the visual acuity. CLINICALHistoryPatients may have decreased vision, photosensitivity, and/or eye pain (from recurrent corneal erosions). This dystrophy usually is autosomal dominant, so it is likely that one of the parents will have lattice corneal dystrophy as well. PhysicalLattice corneal dystrophy is characterized by branching, refractile lattice lines, which are observed best in retroillumination. In the most common form, type 1 lattice dystrophy, the refractile lines are more prominent centrally than peripherally. Later in life, stromal haze can develop. Eventually, significant stromal scarring and subepithelial fibrosis may occur. CausesThe genetic defect of lattice dystrophy has been mapped to the BIG H3 gene of chromosome 5q. Other corneal dystrophies also have genetic defects of the BIG H3 gene, including granular dystrophy, Avellino dystrophy, and Reis-Bückler dystrophy. DIFFERENTIALSCorneal Erosion, Recurrent Dystrophy, Granular Dystrophy, Macular WORKUPLab Studies
Procedures
Histologic FindingsThe deposits are amyloid, which stain orange-red with Congo red. They also stain with periodic-acid Schiff (PAS) and Masson trichrome. Under polarized light, the deposits exhibit birefringence and red-green dichroism. TREATMENTMedical CareWhen recurrent erosions occur with this condition, they are treated similar to any other form of recurrent erosion. Under the care of an ophthalmologist, a bandage contact lens along with antibiotics can be prescribed. Alternatively, patching with an antibiotic ointment can be used. Once the acute episode of recurrent erosion has resolved, preventative treatments may include Muro 128 drops, lubrication drops, and lubricating ointment at bedtime. If recurrent corneal erosions occur despite medical therapy, then excimer laser treatment (PTK) may be considered. Surgical CareExcessive corneal erosions or mild visual decreases can be treated with PTK. The excimer laser removes the opacities, smooths the corneal surface, and allows the epithelium to re-adhere more tightly. If the visual acuity drops and the opacities are deep, a lamellar or full-thickness corneal transplant can be performed. Although the success rate for a corneal transplant is very high, lattice deposits can recur. MEDICATIONMedical therapy for recurrent corneal erosions includes hypertonic saline, which is believed to increase adherence of the epithelium to underlying stroma. Lubrication also may help prevent further corneal erosions.
Drug Category: Hypertonic salineDehydrates epithelium, allowing epithelium to adhere better to underlying stroma.
Drug Category: Lubricating dropsCan moisten ocular surface, and decrease number of recurrent erosion episodes.
FOLLOW-UPFurther Outpatient Care
Complications
Prognosis
Patient Education
MISCELLANEOUSMedical/Legal Pitfalls
Special Concerns
MULTIMEDIA
REFERENCES
Article Last Updated: Mar 15, 2006 | |||||||||||||||||||||||||||||||||||||||||||||||||||||